D-Wave Quantum Inc.

🇺🇸New York Stock Exchange
Back to all articles
D-Wave Quantum Inc. stock analysis QBTS overview
Somewhat Bullish +50

D-Wave Quantum (QBTS) Surges Nearly 13% on CEO Summit Anticipation

📈 D-Wave Quantum (QBTS) shares surged approximately 12.9% today on positive market sentiment surrounding upcoming CEO Dr. Alan Baratz's summit appearance.

💼 CEO Dr. Alan Baratz is set to present at the Semafor World Economy summit, where he will discuss commercial quantum-AI implementations and recent technological milestones.

🚀 The broader quantum computing sector saw gains driven by geopolitical developments and a positive reception to competitor Rigetti's new hardware announcement.

📊 Wall Street analysts maintain a consensus "Moderate Buy" rating with an average price target of $36.50, suggesting over 100% upside from current levels.

🏦 Recent analyst activity has included downward revisions on targets by Roth MKM, Mizuho, and Needham, while Zacks Research issued a "Strong Sell" rating.

⚠️ The company's latest quarterly report missed expectations, posting EPS of $(0.09) versus an expected loss of $(0.05) and revenue of $2.75M against $3.74M forecasts.

📉 QBTS currently trades below its 50-day and 200-day moving averages and remains down nearly 44% year-to-date as of Monday's close near $14.67.

🤝 Corporate insiders have recently reduced holdings, with two directors divesting shares in March and total insider sales reaching roughly $1.75M over the past quarter.

💼 Institutional investors have increased exposure, with AQR Capital Management expanding its position by 201% and Royal Bank of Canada boosting holdings by nearly 60%.

📉 The firm's financial metrics reflect ongoing challenges, including a negative return on equity of 58.58% and a net margin of -1,444.10%.

💰 Analyst projections for full-year EPS remain at $(0.41) for the current fiscal period.

📉 Trading volume registered approximately 16.3 million shares, which is roughly 41% below typical daily levels.

Bullish Signals
  • Shares advanced approximately 12.9% as market participants positioned themselves ahead of CEO Dr. Alan Baratz's appearance at the Semafor World Economy summit.
  • D-Wave Quantum (QBTS) received additional momentum from broader quantum computing sector strength and Rigetti's new hardware announcement.
  • Analysts maintain a "Moderate Buy" consensus with an average target of $36.50, representing potential upside of more than 100% from current levels.
  • Fourteen analysts have assigned Buy ratings to QBTS, indicating sustained institutional interest in the company's long-term prospects.
  • Institutional investors are increasing their positions: AQR Capital Management expanded holdings by 201% during Q1 and Royal Bank of Canada boosted its position by 59.8%.
  • Despite missing short-term earnings expectations, revenue still achieved 21.7% year-over-year growth, demonstrating top-line expansion.
  • Benchmark maintained its Buy stance with a $35 price objective, reinforcing confidence in the stock despite recent forecast reductions from other firms.
Risk Factors
  • D-Wave Quantum's latest quarterly report disappointed Wall Street expectations, posting EPS of ($0.09) versus the expected loss of ($0.05), while revenue of $2.75M fell significantly short of the $3.74M consensus forecast.
  • The company faces ongoing financial headwinds with a negative return on equity of -58.58% and an alarming net margin of -1,444.10%, indicating severe profitability challenges.
  • Corporate insiders have reduced their holdings significantly, with two board members selling shares and a total cumulative divestment of 72,898 shares valued at approximately $1.75M in the past quarter, signaling lack of confidence.
  • The stock remains depressed relative to key technical indicators, trading beneath its 50-day moving average of $17.53 and its 200-day moving average of $24.61.
  • Analyst consensus includes bearish pressure with multiple firms reducing price targets; Roth MKM lowered its target from $40 to $30, Mizuho from $46 to $40, and Needham from $48 to $40.
  • Zacks Research issued a "Strong Sell" rating in March, representing a significant dissenting viewpoint from the broader analyst group.
  • Analyst projections for full-year EPS call for a loss of ($0.41), reinforcing expectations of continued financial deterioration for the current fiscal period.
Full Analysis
D-Wave Quantum (QBTS) shares surged nearly 13%, advancing to an intraday peak of $14.79 before closing near $14.67, driven primarily by anticipation surrounding CEO Dr. Alan Baratz's presentation at the upcoming Semafor World Economy summit. The rally was further supported by broader positive dynamics within the quantum computing sector, including recent geopolitical developments and a notable hardware announcement from competitor Rigetti. Despite the stock's strong performance, trading volume registered approximately 16.3 million shares, which was about 41% below typical daily levels, while the stock continues to trade beneath its 50-day moving average of $17.53 and 200-day moving average of $24.61. Underlying fundamentals remain mixed following the company's quarterly report released on February 26th, which disappointed Wall Street expectations. The firm reported earnings per share of ($0.09) compared to a forecast of ($0.05), and revenue came in at $2.75 million against projections of $3.74 million, though it still achieved 21.7% year-over-year growth. Financial metrics also highlighted ongoing challenges, with a negative return on equity of 58.58% and a net margin of -1,444.10%. On the insider front, corporate activity showed divergence, as board members Rohit Ghai and John Dilullo reduced their holdings, contributing to a total insider sale of 72,898 shares valued at roughly $1.75 million in the past quarter. The analyst community maintains a "Moderate Buy" consensus with an average price target of $36.50, implying potential upside of over 100% from current levels based on recent session data. Of the fourteen analysts covering the stock, fourteen have assigned Buy ratings while two maintain Sell recommendations, with Benchmark maintaining its Buy stance at $35. However, recent revisions have tempered near-term optimism, as major firms including Roth MKM, Mizuho, and Needham reduced their price targets, while Zacks Research issued a "Strong Sell" rating in March. Institutional interest has grown significantly compared to insider selling; institutional shareholders collectively control 42.47% of outstanding shares, with AQR Capital Management expanding its position by 201% in Q1 and Royal Bank of Canada boosting its stake by nearly 60%. Analyst projections for full-year EPS currently stand at ($0.41) for the current fiscal period.